One month after President Trump and his Department of Health and Human Services (HHS) Secretary Alex Azar rolled out the administration's blueprint to lower prescription drug prices, the executive branch's proposal took center stage in the legislative branch in a June 12 Senate Committee on Health, Labor, Education and Pensions hearing.
It was evident since the rollout of the blueprint that the proposals would require a series of HHS administrative actions...